Document is current

Any future updates will be listed below

Reply to: “Methodological Concerns Regarding: “Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?”” by Ahlström

Crossref DOI link: https://doi.org/10.1245/s10434-024-16299-1

Published Online: 2024-10-05

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark